Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML
Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML
Recruiting · NCT07617285 · Registry updated 2026-06-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML | acute myeloid leukemia | Recruiting | Phase 1 | 2026-06-01 | NCT07617285 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CARsgen Therapeutics Co., Ltd. | 20 |
| Peking University People's Hospital | 269 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University People's Hospital | Beijing | China | 58 |